OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 13 citing articles:

A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer
Amelia Acha‐Sagredo, Pietro Andrei, Kalum Clayton, et al.
Cancer Cell (2025)
Open Access

Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?
Marwa Abdel Hamid, Lorenz M. Pammer, Theresa Lentner, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 10, pp. 1258-1270
Open Access | Times Cited: 5

Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer
C. Salva de Torres, Iosune Baraibar, Nadia Saoudi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6967-6967
Open Access | Times Cited: 3

Immunotherapy in Colorectal Cancer — Finding the Achilles’ Heel
Robin Park, Anwaar Saeed
NEJM Evidence (2024) Vol. 3, Iss. 6
Closed Access | Times Cited: 2

Role played by MDSC in colitis-associated colorectal cancer and potential therapeutic strategies
Kang Wang, Yun Wang, Kai Yin
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 1

A Case Report of Envafolimab in the Treatment of Microsatellite Stable (MSS) Metastatic Colon Cancer
Yunshan Yang, Xu Luo, Li Dai, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 1137-1144
Open Access | Times Cited: 1

Zanzalintinib (XL092): a next-generation tyrosine kinase inhibitor—comprehensive review of early safety & efficacy data
James Yu, Robin Park, Alireza Tojjari, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 9, pp. 887-895
Closed Access

Spatial predictors of response to immunotherapy in microsatellite stable metastatic colorectal cancer
Raghav Sundar, Joan Choo, Willa Wen‐You Yim, et al.
Research Square (Research Square) (2024)
Open Access

Current state and future prospects of spatial biology in colorectal cancer
Francisco Carranza, Fernando C. Diaz, Maria Ninova, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access

Systemic Therapy for Metastatic Colon Cancer: New Frontiers
Yoanna S Pumpalova
Clinics in Colon and Rectal Surgery (2024)
Closed Access

STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer
Anwaar Saeed, Josep Tabernero, Aparna R. Parikh, et al.
Future Oncology (2024) Vol. 20, Iss. 24, pp. 1733-1743
Closed Access

An Evolving Landscape: New Therapies for Metastatic Colorectal Cancer
Christiana Mo, Bhawneet Chadha, Chaoyuan Kuang
Clinical Colorectal Cancer (2024) Vol. 23, Iss. 4, pp. 337-345
Closed Access

Page 1

Scroll to top